Emerging evidence suggests that knockout of SREBP1 can reduce glycolysis, FA oxidation, and mitochondrial respiration levels, and thus inhibit xenograft tumor occurrence and growth in vivo.43 This evidence concerns the gene SREBF1 and neoplasm.